Abstract
Lifetime prevalence of significant depressive symptoms is 13% to 20% and 3.7% to 6.7% for major depressive disorder. Depressive patients experience a wide range of clinical symptoms ranging from lack of pleasure and sleeping problems to psychomotor retardation or even committing suicide in extreme cases.
| Original language | English |
|---|---|
| Title of host publication | Essential Clinical Anesthesia Review |
| Subtitle of host publication | Keywords, Questions and Answers for the Boards |
| Publisher | Cambridge University Press |
| Pages | 51-55 |
| Number of pages | 5 |
| ISBN (Electronic) | 9781139584005 |
| ISBN (Print) | 9781107681309 |
| DOIs | |
| Publication status | Published - 1 Jan 2015 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bipolar disorder: Lithium Lithium toxicity Anesthetic Considerations
- Depression: Antidepressants (tricyclic antidepressants SSRIs SNRIs MAOIs) Anesthetic implications Serotonin syndrome Serotonin syndrome
- Schizophrenia: Antipsychotics (typical Atypical) Anesthetic considerations Neuroleptic malignant Syndrome
Fingerprint
Dive into the research topics of 'Anesthetic considerations in psychiatric disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver